TMCnet News
CellFE Announces May 2024 Conference PresentationsALAMEDA, Calif., April 25, 2024 /PRNewswire/ -- CellFE Inc., a life sciences tools company with a novel microfluidics-based cellular engineering platform, announced today an upcoming presentation by CSO Todd Sulchek, PhD, at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, taking place May 7-11, 2024 in Baltimore, MD. The company will also present an accepted abstract showcasing the company's microfluidic approach for high efficiency CRISPR/Cas9 knockout via sequential editing. "We are excited to return to ASGCT this year and present new data that validates the advantage of our microfluidic technology in enabling rapid sequential editing with superior viability and transfection efficiencies," said Dr. Sulchek. "By unlocking this sequential editing process for complex payloads, our technology delivers high yields of edited cells with reduced risk of genomic translocations – currently a key roadblock for cell therapy manufacturers." Sponsor Presentation Details: Poster Presentation Details: Abstract Number: 756 Date and Time: Wednesday, May 8, 2024, 12 p.m. ET Location: Exhibit Hall CellFE will be exhibiting at Booth #828 at ASGCT from May 7-11th in Baltimore, MD. Abstracts are available to the public at https://annualmeeting.asgct.org/. A copy of the sponsor presentation and abstract will be available at www.cellfebiotech.com after the conference concludes. About CellFE Inc. View original content to download multimedia:https://www.prnewswire.com/news-releases/cellfe-announces-may-2024-conference-presentations-302127872.html SOURCE CellFE |